Biotech News
Progyny, Inc. Announces First Quarter 2026 Results
investors.progyny.com2026-05-07 20:03 EST
Reports Record First Quarter Revenue of $328.5 Million Early Selling Season Activity Reflects Robust Demand for Women's Health and Family Building Solutions Returned Value to Shareholders Through Repurchase of 8.8 Million Shares to Date Since November NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) --
